Caspase-mediated cleavage of tau protein represents a critical pathological modification in Progressive Supranuclear Palsy (PSP) that promotes tau aggregation, enhances neurotoxicity, and generates truncated tau fragments with distinct seeding properties. Caspase cleavage removes regulatory domains, exposes hydrophobic regions, and produces aggregation-prone fragments that serve as seeds for filament formation. This mechanism represents a key link between apoptotic signaling and tau pathology in 4R-tauopathies.
Caspases in PSP can be activated through multiple pathways:
Intrinsic (mitochondrial) pathway: Cytochrome c release triggers apoptosome formation, activating caspase-9 and downstream executioner caspases
Extrinsic pathway: Death receptor engagement activates caspase-8
ER stress pathway: Caspase-4/12 activation (in rodents) or caspase-4 in human astrocytes
Inflammasome-mediated: Caspase-1 activation through NLRP3 inflammasome can cross-talk to executioner caspases
Tau Cleavage Sites
...
PSP Tau Caspase Cleavage and Truncation
Overview
Caspase-mediated cleavage of tau protein represents a critical pathological modification in Progressive Supranuclear Palsy (PSP) that promotes tau aggregation, enhances neurotoxicity, and generates truncated tau fragments with distinct seeding properties. Caspase cleavage removes regulatory domains, exposes hydrophobic regions, and produces aggregation-prone fragments that serve as seeds for filament formation. This mechanism represents a key link between apoptotic signaling and tau pathology in 4R-tauopathies.
Significance: Most studied truncation product in PSP
Properties:
Severely impaired microtubule binding
Enhanced aggregation propensity
Forms stable oligomers
Transcellular propagation capacity
Found in PSP brain tissue at elevated levels
TauΔC393 (Tau 1-393)
Generated by: Caspase-3
Significance: Generates tau fragment containing both N-terminal projection domain and microtubule-binding repeats
Properties:
Accelerated filament formation
Reduced solubility
Interaction with full-length tau to co-aggregate
TauN-terminus (1-13)
Generated by: Caspase-6 cleavage at Asp13
Significance: Produces highly aggregation-prone fragment
Properties:
Seeds tau aggregation efficiently
Found in PSP neurons and glia
Correlates with disease severity
Molecular Mechanisms
Cleavage-Induced Conformational Changes
Caspase cleavage at Asp421 removes the C-terminal tail, which normally acts as a "chaperone" keeping tau in a soluble, microtubule-bound state. This removal leads to:
Loss of negative charge: C-terminal region contains acidic residues that maintain solubility
Exposure of hydrophobic residues: microtubule-binding repeats become more accessible
Enhanced β-sheet formation: truncation promotes conformational transition to β-sheet rich state
Reduced tau-tau repulsion: removes steric hindrance between tau molecules
Seeding and Propagation
Truncated tau fragments serve as superior seeds compared to full-length tau:
| Property | Full-Length Tau | Caspase-Truncated Tau | |----------|-----------------|----------------------| | Aggregation lag time | 48-72 hours | 4-8 hours | | Seed efficiency | Baseline | 5-10x higher | | Filament morphology | Variable | More uniform | | Cell-to-cell transfer | Moderate | Enhanced |
Interaction with Phosphorylation
Caspase cleavage and phosphorylation synergistically promote pathology:
Phosphorylation before cleavage: Phosphorylated tau is more susceptible to caspase cleavage
Cleavage before phosphorylation: Truncated tau is phosphorylated more efficiently by GSK-3β and CDK5
Feedback loop: Cleavage products activate kinases that further promote phosphorylation and additional cleavage
Regional Patterns in PSP
Brain Region Distribution
Caspase-cleaved tau (detected by anti-tauC3 antibodies) shows distinct regional patterns in PSP:
Globus pallidus internus: High density of tauC3+ neurons and terminals
Substantia nigra: Prominent in remaining neurons (especially pars reticulata)
Brainstem nuclei: Red nucleus, oculomotor nucleus, pontine nuclei
Cerebellar dentate nucleus: Moderate levels
Frontal cortex: Layer 3 pyramidal neurons
Cell-Type Specificity
Neurons: Primary source of caspase-cleaved tau; correlates with NFT burden
Oligodendrocytes: Coiled bodies show caspase cleavage in PSP
Astrocytes: Tau-positive astrocytes in PSP show caspase activation
Biomarker Potential
CSF Biomarkers
Caspase-generated tau fragments can be detected in cerebrospinal fluid:
TauC3 in CSF: Elevated in PSP vs. healthy controls
Fragments: 20-25 kDa fragments corresponding to cleavage products
Diagnostic utility: AUROC 0.72-0.78 for PSP vs. PD differentiation
Blood Biomarkers
Plasma tauC3: Technical challenges due to low abundance
Extracellular vesicle tau: Truncated tau in neuron-derived EVs shows promise
Imaging Correlates
Tau PET: Caspase-cleaved tau shows different binding patterns than total tau
PET ligands: Novel tracers under development that preferentially bind truncated tau